EFC (I)
Quarterly Results Analysis [Jun2026]
EFC (I) Quarterly Results
| Consolidated | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹283 Cr | ₹293 Cr | ₹270 Cr | ₹255 Cr | ₹220 Cr | ₹211 Cr | ₹177 Cr | ₹166 Cr |
| Expenses | ₹160 Cr | ₹149 Cr | ₹158 Cr | ₹144 Cr | ₹117 Cr | ₹102 Cr | ₹85 Cr | ₹87 Cr |
| Operating Income | ₹123 Cr | ₹144 Cr | ₹112 Cr | ₹111 Cr | ₹102 Cr | ₹109 Cr | ₹93 Cr | ₹79 Cr |
| Other Income | ₹11 Cr | ₹4 Cr | ₹7 Cr | ₹2 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr |
| Interest | ₹10 Cr | ₹28 Cr | ₹10 Cr | ₹6 Cr | ₹12 Cr | ₹15 Cr | ₹18 Cr | ₹7 Cr |
| Depreciation | ₹23 Cr | ₹35 Cr | ₹26 Cr | ₹31 Cr | ₹28 Cr | ₹30 Cr | ₹26 Cr | ₹21 Cr |
| Profit Before Tax | ₹101 Cr | ₹85 Cr | ₹82 Cr | ₹76 Cr | ₹66 Cr | ₹71 Cr | ₹52 Cr | ₹56 Cr |
| Profit After Tax | ₹71 Cr | ₹69 Cr | ₹62 Cr | ₹57 Cr | ₹47 Cr | ₹48 Cr | ₹40 Cr | ₹37 Cr |
| EPS | ₹4.66 | ₹4.98 | ₹4.54 | ₹4.41 | ₹4.29 | ₹4.34 | ₹4.37 | ₹2.98 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| EFC (I) | 7.8% | 3.9% | -41.4% |
| SAGILITY | 3.4% | 2.1% | -4.1% |
| SYNGENE INTERNATIONAL | 4% | 0.4% | -39.1% |
| PRIME FOCUS | 6.9% | 4.8% | 81.9% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | 3.8% | 6.1% | 0.8% |
| INDEGENE | 0.6% | 12.2% | -2.7% |
| NESCO | -1.2% | -2.8% | -29.4% |
| LATENT VIEW ANALYTICS | -2.8% | -12.2% | -34.8% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -2.5% | -6.9% | 32.2% |
EFC (I) Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -3.41 % |
| Y-o-Y | 28.80 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹283 Cr | -3.41 | |
| Mar2026 | ₹293 Cr | 8.64 | |
| Dec2025 | ₹270 Cr | 5.89 | |
| Sep2025 | ₹255 Cr | 15.92 | |
| Jun2025 | ₹220 Cr | 4.08 | |
| Mar2025 | ₹211 Cr | 19.05 | |
| Dec2024 | ₹177 Cr | 6.49 | |
| Sep2024 | ₹166 Cr | - | |
EFC (I) Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -14.36 % |
| Y-o-Y | 20.25 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹123 Cr | -14.36 | |
| Mar2026 | ₹144 Cr | 28.54 | |
| Dec2025 | ₹112 Cr | 0.80 | |
| Sep2025 | ₹111 Cr | 8.37 | |
| Jun2025 | ₹102 Cr | -6.46 | |
| Mar2025 | ₹109 Cr | 17.98 | |
| Dec2024 | ₹93 Cr | 16.78 | |
| Sep2024 | ₹79 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -11.32 % |
| Y-o-Y | -6.64 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 43.47% | -11.32 | |
| Mar2026 | 49.02% | 18.32 | |
| Dec2025 | 41.43% | -4.80 | |
| Sep2025 | 43.52% | -6.53 | |
| Jun2025 | 46.56% | -10.12 | |
| Mar2025 | 51.8% | -0.90 | |
| Dec2024 | 52.27% | 9.65 | |
| Sep2024 | 47.67% | - | |
EFC (I) Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 2.89 % |
| Y-o-Y | 51.53 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹71 Cr | 2.89 | |
| Mar2026 | ₹69 Cr | 10.33 | |
| Dec2025 | ₹62 Cr | 10.12 | |
| Sep2025 | ₹57 Cr | 21.21 | |
| Jun2025 | ₹47 Cr | -2.52 | |
| Mar2025 | ₹48 Cr | 18.52 | |
| Dec2024 | ₹40 Cr | 10.69 | |
| Sep2024 | ₹37 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 6.55 % |
| Y-o-Y | 17.66 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 25.05 % | 6.55 | |
| Mar2026 | 23.51 % | 1.56 | |
| Dec2025 | 23.15 % | 4.00 | |
| Sep2025 | 22.26 % | 4.56 | |
| Jun2025 | 21.29 % | -6.34 | |
| Mar2025 | 22.73 % | -0.44 | |
| Dec2024 | 22.83 % | 3.91 | |
| Sep2024 | 21.97 % | - | |
EFC (I) Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -6.43 % |
| Y-o-Y | 8.62 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹4.66 | -6.43 | |
| Mar2026 | ₹4.98 | 9.69 | |
| Dec2025 | ₹4.54 | 2.95 | |
| Sep2025 | ₹4.41 | 2.80 | |
| Jun2025 | ₹4.29 | -1.15 | |
| Mar2025 | ₹4.34 | -0.69 | |
| Dec2024 | ₹4.37 | 46.64 | |
| Sep2024 | ₹2.98 | - | |
You may also like the below Video Courses
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs NESCO LTD